Vicarius Leadership Team – Executive Profiles

Vice President, Commercial Strategy

Professional Experience

General Manager EMEA Ultrapheresis Oncology, Parker Hannifin Lausanne, Switzerland

Head Central Europe, DACH & CEE, Piramal Imaging, Munich, Germany

Head of Commercial Strategy Oncology International, GSK Biologics, Brussels, Belgium

Business Unit Head, Oncology CEE & Russia, Genzyme, Constance, Germany

Head Oncology Asia-Pacific, Bayer Healthcare, Singapore

Head Marketing & Sales Asia-Pacific, Bayer Healthcare, Singapore

Business Unit Head Neurology Germany, Bayer Healthcare (Schering), Berlin, Germany

Head Global Strategic Marketing, Multiple Sclerosis, Bayer Healthcare (Schering) Berlin, Germany

 

Key Achievements

Bayer

  • Launched first interferon in multiple sclerosis as global marketing lead
  • Built the commercial organization for oncology in Asia-Pacific and achieved market leadership with launched blockbuster product Nexavar in liver and renal cancer as Head of Oncology AP

 

Genzyme

  • Built the commercial organization for oncology in CEE and Russia, launched hemato-oncology portfolio as Head Oncology CEE & Russia

 

Glaxo Smith Kline

  • Prepared, launched and developed international business strategy for oncological immunotherapy as Head of Commercial Strategy International

 

Piramal Imaging

  • Built the commercial organization and achieved market leadership with molecular imaging diagnostic for amyloid plaques (Alzheimer’s disease) in Central Europe (DACH and CEE) for start-up Piramal Imaging

 

Education

Postdoctoral Scientist, Max-Planck-Institute, Cologne, Germany

Ph.D., Biology, University Cologne, Germany

Dipl.-rer. nat., University Cologne, Germany

 

Nationality

German

Languages

German, English, French

 

Other Executive Team

Member Profiles

  • President and CEO
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Pre-Approval Regulatory Affairs
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Post-Approval Regulatory Affairs
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Chief Compliance Officer
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Vice President, Market Access
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Head of Business Development,
  • Legal & External Affairs
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Chief Medical/Scientific Officer
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Chief Financial Officer
  •